Literature DB >> 25151011

Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.

Tae-In Kam1, Youngdae Gwon, Yong-Keun Jung.   

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease. Although a major cause of AD is the accumulation of amyloid-β (Aβ) peptide that induces neuronal loss and cognitive impairments, our understanding of its neurotoxic mechanisms is limited. Recent studies have identified putative Aβ-binding receptors that mediate Aβ neurotoxicity in cells and models of AD. Once Aβ interacts with a receptor, a toxic signal is transduced into neurons, resulting in cellular defects including endoplasmic reticulum stress and mitochondrial dysfunction. In addition, Aβ can also be internalized into neurons through unidentified Aβ receptors and induces malfunction of subcellular organelles, which explains some part of Aβ neurotoxicity. Understanding the neurotoxic signaling initiated by Aβ-receptor binding and cellular defects provide insight into new therapeutic windows for AD. In the present review, we summarize the findings on Aβ-binding receptors and the neurotoxicity of oligomeric Aβ.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25151011     DOI: 10.1007/s00018-014-1706-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  133 in total

1.  Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress.

Authors:  T Yoneda; K Imaizumi; K Oono; D Yui; F Gomi; T Katayama; M Tohyama
Journal:  J Biol Chem       Date:  2001-01-29       Impact factor: 5.157

2.  Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

Authors:  O Wirths; G Multhaup; C Czech; V Blanchard; S Moussaoui; G Tremp; L Pradier; K Beyreuther; T A Bayer
Journal:  Neurosci Lett       Date:  2001-06-22       Impact factor: 3.046

3.  Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N-methyl-d-aspartate receptor in mature hippocampal cultures treated with amyloid-β oligomers.

Authors:  Rui O Costa; Pascale N Lacor; Ildete L Ferreira; Rosa Resende; Yves P Auberson; William L Klein; Catarina R Oliveira; Ana C Rego; Cláudia M F Pereira
Journal:  Aging Cell       Date:  2012-07-16       Impact factor: 9.304

4.  Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death.

Authors:  Wataru Kudo; Hyun-Pil Lee; Wen-Quan Zou; Xinglong Wang; George Perry; Xiongwei Zhu; Mark A Smith; Robert B Petersen; Hyoung-gon Lee
Journal:  Hum Mol Genet       Date:  2011-11-18       Impact factor: 6.150

5.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

6.  Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.

Authors:  Silke Walter; Maryse Letiembre; Yang Liu; Holger Heine; Botond Penke; Wenlin Hao; Barbara Bode; Nicole Manietta; Jessica Walter; Walter Schulz-Schuffer; Klaus Fassbender
Journal:  Cell Physiol Biochem       Date:  2007

7.  Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.

Authors:  Erika Chung; Yong Ji; Yanjie Sun; Richard J Kascsak; Regina B Kascsak; Pankaj D Mehta; Stephen M Strittmatter; Thomas Wisniewski
Journal:  BMC Neurosci       Date:  2010-10-14       Impact factor: 3.288

Review 8.  Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.

Authors:  Masahiro Kawahara; Midori Negishi-Kato; Yutaka Sadakane
Journal:  Expert Rev Neurother       Date:  2009-05       Impact factor: 4.618

9.  Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.

Authors:  Justin M Nussbaum; Stephan Schilling; Holger Cynis; Antonia Silva; Eric Swanson; Tanaporn Wangsanut; Kaycie Tayler; Brian Wiltgen; Asa Hatami; Raik Rönicke; Klaus Reymann; Birgit Hutter-Paier; Anca Alexandru; Wolfgang Jagla; Sigrid Graubner; Charles G Glabe; Hans-Ulrich Demuth; George S Bloom
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962

10.  Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1.

Authors:  Jo V Rushworth; Heledd H Griffiths; Nicole T Watt; Nigel M Hooper
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

View more
  22 in total

1.  Uncontrolled SFK-mediated protein trafficking in prion and Alzheimer's disease.

Authors:  Edward Málaga-Trillo; Katharina Ochs
Journal:  Prion       Date:  2016-09-02       Impact factor: 3.931

2.  Inhibition of PTEN Attenuates Endoplasmic Reticulum Stress and Apoptosis via Activation of PI3K/AKT Pathway in Alzheimer's Disease.

Authors:  Weigang Cui; Songtao Wang; Zhongping Wang; Zhiyong Wang; Chunli Sun; Yinghua Zhang
Journal:  Neurochem Res       Date:  2017-08-18       Impact factor: 3.996

3.  Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture.

Authors:  Hans Zempel; Frank J A Dennissen; Yatender Kumar; Julia Luedtke; Jacek Biernat; Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

Review 4.  Vascular and non-vascular contributors to memory reduction during traumatic brain injury.

Authors:  Mariam Charkviani; Nino Muradashvili; David Lominadze
Journal:  Eur J Neurosci       Date:  2019-03-12       Impact factor: 3.386

Review 5.  β-Amyloid Peptide: the Cell Compartment Multi-faceted Interaction in Alzheimer's Disease.

Authors:  Pasquale Picone; Domenico Nuzzo; Daniela Giacomazza; Marta Di Carlo
Journal:  Neurotox Res       Date:  2019-12-06       Impact factor: 3.911

6.  MEK1/2 inhibition rescues neurodegeneration by TFEB-mediated activation of autophagic lysosomal function in a model of Alzheimer's Disease.

Authors:  Yoon Sun Chun; Mi-Yeon Kim; Tae-In Kam; Sungho Han; Sun-Young Lee; Mi Jeong Kim; Tae-Joon Hong; Jae Kyong Jeon; Dulguun Ganbat; Hyoung Tae Kim; Sang Seong Kim
Journal:  Mol Psychiatry       Date:  2022-08-10       Impact factor: 13.437

7.  Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits.

Authors:  Hye Yun Kim; Dongkeun K Lee; Bo-Ryehn Chung; Hyunjin V Kim; YoungSoo Kim
Journal:  J Vis Exp       Date:  2016-03-16       Impact factor: 1.355

8.  FcγRIIb-SHIP2 axis links Aβ to tau pathology by disrupting phosphoinositide metabolism in Alzheimer's disease model.

Authors:  Tae-In Kam; Hyejin Park; Youngdae Gwon; Sungmin Song; Seo-Hyun Kim; Seo Won Moon; Dong-Gyu Jo; Yong-Keun Jung
Journal:  Elife       Date:  2016-11-11       Impact factor: 8.140

Review 9.  Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease.

Authors:  Anna Chiarini; Ubaldo Armato; Daisong Liu; Ilaria Dal Prà
Journal:  Front Physiol       Date:  2016-04-26       Impact factor: 4.566

10.  A method for the expression of fibroblast growth factor 14 and assessment of its neuroprotective effect in an Alzheimer's disease model.

Authors:  Lusheng Wang; Rongrong Jing; Xing Wang; Baohui Wang; Keke Guo; Jungang Zhao; Shuang Gao; Nuo Xu; Xuan Xuan
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.